Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absence, accomplish, accrual, Accupril, accused, accustomed, adequacy, Advil, aggressive, allegedly, ambiguity, American, Amoxil, analyzed, analyzing, Androgel, arbitration, argued, arise, arising, ascertain, assimilation, assist, assumption, Augmentin, bargain, biotechnology, bloodstream, built, BusSpar, byEITF, cabergoline, calendar, Canada, candidate, Capoten, Capozide, cefprozil, Cefzil, cephalexin, cessation, chain, Chancery, channel, cholestyramine, choose, circumvented, circumvention, citizen, Claritin, clonazepam, closest, Clostridium, compound, Conflict, convince, coverage, damage, DC, debarment, defraud, denial, Department, depletion, deployed, detrimental, diarrhea, Diego, discharge, diversion, divert, divested, divestiture, Duragesic, Endo, enlarged, Erie, ES, failed, fiduciary, flavoxate, forum, galantamine, gathered, glimepiride, Glucovance, greatly, Guaranty, harm, human, Ibuprofen, imposition, impracticable, IND, indemnity, indenture, indirectly, inRule, intensify, internet, interruption, intrinsic, invent, Justice, Keflex, lapse, leflunomide, legislation, legislative, lengthy, liberal, likewise, lobbied, loyalty, magnitude, main, maker, memo, mentioned, Mercatopurine, metabolism, Mevacor, microbiological, Mississippi, molecular, Motrin, NanoCrystal, nationwide, NE, nitroflurantoin, notification, notified, Nuprin, ofRegulation, oncology, onForm, Orchid, pediatric, persuading, physician, population, preclinical, prescribed, prescribing, Prilosec, proceed, prove, Prozac, Purinethol, quick, Ranbaxy, ranitidine, ratably, read, receipt, recordkeeping, recouped, remand, remanded, remedy, remedying, Remeron, requisite, Restoration, retrospectively, revoked, ribasphere, Room, Rx, San, Sante, secrecy, SEPPAA, side, site, skilled, sotalol, stop, study, suitable, Sumycin, Sunday, susceptible, Synaptech, team, tentively, thisForm, thwart, tolerance, Township, toxicology, tracking, train, trend, TriCor, TTS, turnaround, Ultracet, unable, uncompetitive, unconditional, undergo, undergoing, unfilled, unpatented, unproven, Unresolved, unvested, USP, Valeant, voluntarily, withdrawn, wrote, Xalatan, xii, XR, Zanaflex, Zantac
Removed:
achievement, adjustment, announcement, ANTIEMETIC, appealing, area, attached, auditor, Auerbach, base, borrowing, BRONCODILATOR, CARDIOVASCULAR, central, Certificate, check, Chemco, cholesterol, ciprofloxacin, consulting, contributor, core, DEC, decrease, delinquent, DIURETIC, doubtful, Easy, equally, exercised, exhibit, filer, fine, GLUCORTICOID, Haifa, Halsey, Hungary, improved, incorporated, incorporation, integration, ISP, Israel, judicially, jurisdiction, kenneth, knowledge, Leiner, Letter, LOSING, lowering, LP, mark, Modification, Nesher, occupied, occupy, Ohio, OVULATION, passed, past, purpose, Ramapo, reached, refer, reflecting, Registration, relation, renewal, restated, restatement, retained, Sano, sawyer, Schering, scott, SEPT, serve, Signature, STIMULANT, SVC, tarriff, torsemide, Trima, volatility
Filing tables
Filing exhibits
- 10-K Annual report
- 21 List of Subsidiaries of the Registrant
- 31.1 Certification of Principal Executive Officer
- 31.2 Certification of Principal Financial Officer
- 32.1 Certification by the Chief Executive Officer Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification by the Chief Financial Officer Pursuant to 18 U.s.c. Section 1350
Related press release
PRX similar filings
Filing view
External links
EXHIBIT 21
List of Subsidiaries
Par Pharmaceutical Companies, Inc.
Percentage of Voting | ||||||||
Securities Owned by Its | ||||||||
Entity | Jurisdiction of Organization | Immediate Parent | ||||||
Par Pharmaceutical, Inc. | Delaware | 100% | ||||||
PRX Pharmaceuticals, Inc. | Delaware | 100% | ||||||
PRI-Research, Inc. | Delaware | 100% | ||||||
Par Pharma Group, Ltd. | Delaware | 100% | ||||||
Nutriceutical Resources, Inc. | New York | 100% | ||||||
ParCare Ltd. | New York | 100% | ||||||
Israel Pharmaceutical Resources LP | Israel | 100% | ||||||
Par SVC, LLC. | New York | 100% | ||||||
Kali Laboratories, Inc. | New Jersey | 100% |
Par Pharmaceutical, Inc.
Percentage of Voting | ||||||||
Securities Owned by Its | ||||||||
Entity | Jurisdiction of Organization | Immediate Parent | ||||||
Par, Inc. | Delaware | 100% |